Anzeige
Mehr »
Samstag, 14.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
319 Leser
Artikel bewerten:
(1)

Aimed Alliance: Women Legislators Seek Regulation of Products Containing Hemp-Derived Cannabinoids

WASHINGTON, DC / ACCESSWIRE / December 6, 2023 / The National Foundation for Women Legislators (NFWL) has passed a resolution calling for tighter regulation of consumer products containing hemp-derived cannabinoids. The resolution urges the U.S. Congress to provide the Food and Drug Administration (FDA) with the authority and resources to regulate consumer products such as CBD oils, and recognizes the need for a new federal regulatory framework and enforcement mechanisms to mitigate product risks and protect consumers from harm.

Consumer products containing hemp-derived cannabinoids are widely available in the interstate marketplace. Examples include balms containing CBD, gummies and lollipops containing delta-8 THC, and vaping products containing delta-10 THC. Many cannabinoid consumer products are promoted with unsubstantiated health claims; others are marketed for their mood-altering effects.

"The lack of federal regulatory clarity surrounding consumer products containing delta-8 THC and other potentially intoxicating hemp-derived cannabinoids frustrates state legislators' efforts to protect their consumers and public health," said Florida Senator Colleen Burton, a member of NFWL who supported the resolution.

Aimed Alliance, a not-for-profit health policy organization, proposed the NFWL resolution, and the NFWL Policy Committee reviewed it and forwarded it to the full membership. Hawaii Senator Lynn DeCoite presented the resolution to the NFWL membership for discussion and a vote during the group's 85th Annual Conference November 16 - 18 in Orlando, Florida.

"Consumer products containing hemp-derived cannabinoids are not subject to federal regulations that help ensure product safety, limit cannabinoid exposure, require safety warnings, and prohibit marketing to children," said Olivia Backhaus, Counsel to Aimed Alliance. "We encourage Congress to authorize and equip the FDA to establish and enforce new rules."

Through the resolution, the NFWL:

  • Recognizes the need for a new federal regulatory framework and enforcement mechanisms for consumer products containing hemp-derived cannabinoids;
  • Acknowledges that adjustments to federal regulations will be essential as additional scientific evidence emerges; and
  • Calls upon Congress to provide the FDA the authorities and resources to regulate consumer products containing hemp-derived cannabinoids to protect consumers and public health.

"NFWL conferences provide elected women a civil, bipartisan forum to discuss policy, and our resolutions enable our membership to express consensus on timely, substantive issues," said Brenna Kehew Sculley, NFWL's Director of Policy & Programming.

View the NFWL resolution here.

View Aimed Alliance's presentation, titled "Cannabinoid Clarity: The Need for Federal Legislation to Protect Consumers, States, and Industry," here.

###

About the National Foundation for Women Legislators (NFWL)

Since 1938, NFWL has served as a forum for elected women from across the country to be empowered through information and experience. NFWL is the oldest organization for elected women in America and the ONLY one that includes women on the city, county and state levels.

About Aimed Alliance

Aimed Alliance is a 501 (c)(3) not-for-profit health policy organization that protects and enhances the rights of health care consumers and providers. For more information, visit aimedalliance.org.

Media Contact

Jonathan Ghent
WritLarge PR LLC
jonathanghent@WritLargePR.com

SOURCE: Aimed Alliance

View source version on accesswire.com:
https://www.accesswire.com/814011/women-legislators-seek-regulation-of-products-containing-hemp-derived-cannabinoids

© 2023 ACCESS Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.